On this page
Gammagard Liquid
Immune Globulin Infusion (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Gammagard Liquid
Proper name
Immune Globulin Infusion (Human)
Licence type
351(a)
BLA number
125105
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 10% MG/ML | Injection | Intravenous, Subcutaneous | Single-Use Bottle | Rx | April 27, 2005 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | June 22, 2019 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |